Curi Bio
@Curi_Bio
Followers
183
Following
92
Media
254
Statuses
369
Accelerating Discovery of Next Generation Human Medicines
Seattle, WA
Joined June 2015
Don't miss this opportunity to explore how to seamlessly transform raw data into advanced functional parameters—characterizing twitch & tetanic contractions as well as calcium & voltage transients—by using a turn-key platform designed for speed & confidence.
0
0
0
Traditional 2D models often fail to predict human clinical outcomes, creating a costly translation gap in drug discovery. Join this #webinar as we demonstrate how to bridge this gap using the Pulse Analysis Software for data collecting. Reserve Today: https://t.co/KAvH6g9tIt
1
0
0
0
0
0
Our latest App Note with @CookMyosite shows how 3D EMTs on the Mantarray platform provide human-relevant data for metabolic & atrophy research, including: 🔹 Quantitative glucose uptake assays 🔹 Inducible atrophy models 🔹 Scalable 3D functional data https://t.co/xw1cjhAXMN
1
0
0
Missed our #TOXINS2026 presentation? Our platform is ideal for high-throughput neurotoxin potency testing and neuromuscular disease modeling. Download our poster to see how 3D NMJs exhibit a distinct force-frequency profile relative to SkM only tissues: https://t.co/JQiPEZRH0P
1
1
1
Curi Bio is coming to #Italy! Senior BD Manager, Hamed Ghazizadeh, is visiting Italy Jan 28-30! Interested in a demo of Mantarray for 3D human-relevant muscle contractility? We pride ourselves on a white-glove approach to your discovery needs. Book today: https://t.co/YpvxgSFcpQ
1
1
1
Join this #webinar to learn how to replace cumbersome, manual data pipelines w/ a turn-key platform designed to unveil decision-driving insights faster. Explore how Pulse Analysis Software unifies workflows to deliver contractility & fluorescence data. ➡️ https://t.co/Lax3Jmvixu
1
1
1
0
0
0
Our poster is live at #TOXINS2026! Discover a previously unreported divergence in force-frequency phenotypes between 3D SkM-only & NMJ tissues. Learn how our iPSC-based platform accelerates neuromuscular disease modeling & neurotoxin potency testing. More: https://t.co/k8gGRkLTwS
1
1
1
The future of neurotoxin potency testing is human-centric. 🧪 Tomorrow at #TOXINS2026, see how innervation alters functional phenotypes within our 3D NMJ model on the Mantarray platform. 📍 Poster P1.23 📅 Jan 14, 17:30-19:30 @ Madrid Marriott Learn More: https://t.co/TGFHg5v7Gq
1
0
0
#CuriBio expands into Asia-Pacific! 🌏 We’re thrilled to launch Curi Bio Co., Ltd—our new #APAC hub following the Quvit Bio acquisition. This brings localized R&D and support to Korea, Japan, & China to accelerate safer medicines worldwide. 💊 Details: https://t.co/ZGHmaaxxeG
1
0
0
Translating neuromuscular therapies requires models that replicate human physiology. At #TOXINS2026, we’re revealing how the #CuriBio 3D #NMJ platform achieves advanced contractile phenotypes, unlocking predictive insights for neuromuscular R&D. https://t.co/wdd83jHzQ1
1
0
0
Read the latest in @JACCJournals: @TenayaThera and team reveal energy metabolism is integral to desmosome function using @CuriBio’s 3D EHT ecosystem. https://t.co/BFPHLD9HWZ
#ARVC #Cardiology #GeneTherapy #3DCellCulture
0
1
1